You're reading the free version. Trader adds the live tape and alerts.
Start tracking
IRD Sale Disclosure
Foundation Fighting Blindness Retinal Degeneration Fund · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$2.76M
Foundation Fighting Blindness Retinal Degeneration Fund Director / Other
IRD
Opus Genetics
IRD
Transaction date
Sep 30, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 2 days later
IRD daily price context
Close on/before transaction
$4.84
Sep 30, 2026
First close after public filing
$4.38
Oct 5, 2026
30-day return after filing
-15.53%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 556,000 shares @ $4.96
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002042266-26-000002
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$2.76M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Opus Genetics, Inc. IRD Current | Sale | Sep 30, 2026 | $2.76M |